Mapi Pharma Ltd.

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety, Tolerability and Efficacy of Semaglutide Depot in Subjects With Type-2 Diabetes Mellitus	Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus	Recruiting	Phase 1 / Phase 2	2026-08-20		NCT07563699
Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine	Schizophrenia Spectrum and Other Psychotic Disorders, bipolar I disorder, depressive disorder, major depressive disorder, mood disorder, psychiatric disorder, schizophrenia	Recruiting	Phase 1 / Phase 2	2026-05-01		NCT07185815

Clinical trials